ABSTRACT
Allergy-like reactions may occur following administration of iodinated contrast media (CM), mostly in at-risk patients (patients with history of previous reaction, history of allergy, co-treated with interleukin-2 or beta-blockers, etc.) but remain generally unpredictable. Severe and fatal reactions are very rare events. All categories of CM may induce such reactions, although first generation (high osmolar CM) have been found to induce a higher rate of adverse events than low osmolar CM. However, no differences were found between the two categories of CM with respect to mortality. Delayed reactions can also occur. There are no differences between the various categories of CM except for non-ionic dimers, which are more likely to induce such effect. Numerous clinical studies have evaluated the prophylactic value of drugs (mostly antihistamines and corticosteroids). Results are unclear and highly variable. Any prevention depends upon the mechanism involved. However, the mechanism of CM-induced allergy-like reaction remains disputed. Relatively recent data revived the hypothesis of a type-I hypersensitivity mechanism. Positive skin tests to CM have been reported. However, the affinity of IgE towards CM has been found to be very low in the only study which actually evaluated it. Other pathophysiological mechanisms (involving direct secretory effects on mast cells or basophils, or activation of the complement system associated or not with the plasma contact system) are also much debated. Anaphylaxis and anaphylactoid reactions are, in the end, clinically undistinguishable.
Subject(s)
Contrast Media/adverse effects , Drug Hypersensitivity , Iodine Compounds/adverse effects , Anaphylaxis/epidemiology , Anaphylaxis/physiopathology , Animals , Drug Hypersensitivity/epidemiology , Drug Hypersensitivity/physiopathology , Drug Hypersensitivity/prevention & control , Humans , Hypersensitivity, Delayed/physiopathology , Risk FactorsSubject(s)
Cardiac Catheterization , Contrast Media/administration & dosage , Contrast Media/adverse effects , Iohexol/analogs & derivatives , Iopamidol/administration & dosage , Iopamidol/adverse effects , Cardiac Catheterization/methods , Double-Blind Method , Electrocardiography , Humans , Incidence , Iohexol/administration & dosage , Iohexol/adverse effects , Prospective Studies , Randomized Controlled Trials as Topic , Ventricular Fibrillation/diagnosis , Ventricular Fibrillation/epidemiologyABSTRACT
Iodinated contrast media are a frequent cause of acute renal failure, especially in patients whose renal function is already impaired. In addition to hydration, which remains the most commonly acknowledged means of protection, numerous pharmacological approaches for the prophylaxis of contrast nephropathy have been tested so far. They include diuretics, calcium channel blockers, adenosine receptor antagonists, N-acetylcysteine, low-dose dopamine and the dopamine D1 receptor agonist fenoldopam, endothelin receptor antagonists, and even captopril. The present review of the literature critically discusses the drugs used to prevent contrast nephropathy from a pharmacological point of view.
